Correlation Between Simris Alg and Egetis Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Simris Alg and Egetis Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Simris Alg and Egetis Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Simris Alg AB and Egetis Therapeutics AB, you can compare the effects of market volatilities on Simris Alg and Egetis Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Simris Alg with a short position of Egetis Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Simris Alg and Egetis Therapeutics.

Diversification Opportunities for Simris Alg and Egetis Therapeutics

-0.04
  Correlation Coefficient

Good diversification

The 3 months correlation between Simris and Egetis is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Simris Alg AB and Egetis Therapeutics AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Egetis Therapeutics and Simris Alg is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Simris Alg AB are associated (or correlated) with Egetis Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Egetis Therapeutics has no effect on the direction of Simris Alg i.e., Simris Alg and Egetis Therapeutics go up and down completely randomly.

Pair Corralation between Simris Alg and Egetis Therapeutics

Assuming the 90 days trading horizon Simris Alg AB is expected to under-perform the Egetis Therapeutics. In addition to that, Simris Alg is 1.46 times more volatile than Egetis Therapeutics AB. It trades about -0.04 of its total potential returns per unit of risk. Egetis Therapeutics AB is currently generating about 0.03 per unit of volatility. If you would invest  489.00  in Egetis Therapeutics AB on September 3, 2024 and sell it today you would earn a total of  72.00  from holding Egetis Therapeutics AB or generate 14.72% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Simris Alg AB  vs.  Egetis Therapeutics AB

 Performance 
       Timeline  
Simris Alg AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Simris Alg AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's forward indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Egetis Therapeutics 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Egetis Therapeutics AB are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Egetis Therapeutics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Simris Alg and Egetis Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Simris Alg and Egetis Therapeutics

The main advantage of trading using opposite Simris Alg and Egetis Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Simris Alg position performs unexpectedly, Egetis Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Egetis Therapeutics will offset losses from the drop in Egetis Therapeutics' long position.
Simris Alg vs. SenzaGen AB
Simris Alg vs. AAK AB
Simris Alg vs. Scibase AB
Simris Alg vs. Scandinavian Enviro Systems
The idea behind Simris Alg AB and Egetis Therapeutics AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Egetis Therapeutics vs. Simris Alg AB
Egetis Therapeutics vs. Immunovia publ AB
Egetis Therapeutics vs. Sedana Medical AB
Egetis Therapeutics vs. KABE Group AB
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA


 
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY